Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
93.8M
-
Number of holders
-
224
-
Total 13F shares, excl. options
-
102M
-
Shares change
-
+2.18M
-
Total reported value, excl. options
-
$3.42B
-
Value change
-
+$9.85M
-
Put/Call ratio
-
4.04
-
Number of buys
-
124
-
Number of sells
-
-127
-
Price
-
$33.54
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) as of Q1 2025
286 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q1 2025.
Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102M shares
.
Largest 10 shareholders include FMR LLC (14M shares), VANGUARD GROUP INC (9.31M shares), BlackRock, Inc. (7.66M shares), WELLINGTON MANAGEMENT GROUP LLP (6.89M shares), Driehaus Capital Management LLC (6.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.11M shares), FARALLON CAPITAL MANAGEMENT LLC (4.61M shares), EcoR1 Capital, LLC (4.29M shares), JANUS HENDERSON GROUP PLC (3.42M shares), and STATE STREET CORP (3.28M shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.